Search

You searched for "foundation"

2578 results found
Eye Healthcare book cover image.

Eye Healthcare: 90 Years of Progress

4 December 2025 | | EYE - General
Eye Healthcare: 90 Years of Progress by Patrick Condon is far more than a historical account, it is a deeply personal, thoughtful and richly illustrated journey through the most transformative decades in ophthalmology, told by one of Ireland’s most respected...

Eyes on Rwanda: Lessons from an international ophthalmology experience

2 October 2025 | | EYE - Cataract, EYE - Glaucoma
On the 26 February 2025, I travelled to Rwanda on the invitation of a former Belfast trainee, Michael Mikhail. Michael is now one of only two vitreoretinal (VR) surgeons in Rwanda, a country with a population of 14 million. Born...

The New Zealand National Eye Centre and the land of the long white cloud

4 October 2023 | | EYE - General
Located southeast of Australia in the South Pacific Ocean, New Zealand (Aotearoa) is home to five million culturally diverse people. Renowned for its lush nature spanning from unexplored forests to active volcanos and snow-capped mountains, New Zealand has become both...

On reflection

4 December 2023 |
Welcome one and all to our festive Eye News Dec/Jan 2024. The arrow of time has flown through 2023, landing us at the year’s end, but not before Santa brings you this special delivery. Aside from the partying and generally...

Retinopathy of prematurity

1 April 2014 | | EYE - Vitreo-Retinal
This review article describes the pathophysiology of retinopathy of prematurity (ROP). The authors start by introducing the condition and its incidence. There is extensive information on the pathophysiology mechanisms involved in the condition to include normal and pathological retinal development....

Preventing blindness from diabetes: planning a programme of service development and research across Malawi

5 April 2022 | | EYE - Vitreo-Retinal, EYE - Imaging, EYE - General
In sub-Saharan Africa 19.4 million people have diabetes; this is projected to rise to 28.6 million by 2030 [1]. Sight loss from diabetes devastates the lives of working people, affecting the financial stability of the families and communities who depend...

Saving sight and changing lives: working with Syrian refugees in Jordan

7 December 2020 | EYE - Cataract, EYE - Refractive, EYE - General
Two ophthalmologists from the Emory Eye Center share their three-year experience of treating refugees in the camps in Jordan. Jordan currently hosts an estimated 1.4 million Syrian people who have fled the war in their home country. Cataract & Cornea...

“Beware of the pigment”

4 August 2021 | | EYE - Glaucoma, EYE - General
Using some captivating artwork, Iheukwumere Duru describes key features of pigment dispersion syndrome. Pigmentary dispersion syndrome (PDS) leads to pigmentary glaucoma (PG) in approximately 35-50% of patients with the condition [1]. PG is the leading cause of non-traumatic blindness in...

Ophthalmology in ancient india, Sushruta’s time and the modern era

1 August 2015 | | EYE - General
While reading an article related to the history of Indian ophthalmology, I came across this description of a surgical procedure: “The doctor warmed the patient’s eye with the breath of his mouth. He rubbed the closed eye of the patient...

Impact of Eye Health Surveys and Partnerships in The Gambia

4 October 2023 | | EYE - General
This article brings together the three national eye health surveys that have been undertaken in The Gambia between 1986 and 2019 and the impact that the results have had nationally and internationally. In it we describe the long-term capacity-strengthening for...

Ophthalmology specialty training applications: a costly affair?

23 August 2021 | | EYE - General
Ophthalmology is one of the most competitive specialties to pursue training in worldwide. In the United Kingdom, the ST1 entry national selection competition ratio for the past few years has ranged between four to five applicants per post [1]. The...

Intravitreal injections delivered by ophthalmic clinical nurse specialists

1 June 2015 | | EYE - Vitreo-Retinal
Intravitreal injections of the anti-vascular endothelial growth factor (anti-VEGF) agent ranibizumab, for the treatment of wet age-related macular degeneration (AMD) was approved by National Institute for Health & Care Excellence (NICE) in 2008 [1]. The Manchester Royal Eye Hospital (MREH),...